[Comparison of intravenous thrombolysis and intracoronary thrombolysis].
Any comparison between intravenous and intracoronary thrombolysis must take into account such elements as the delays imposed by coronary arteriography, the extra cost of the procedure, etc., but ultimately the answer can only be provided by a controlled trial comparing the two approaches. To give truly significant results, this trial should fulfill several requirements concerning the time of randomization to treatments, the procedure to be followed in each group and the criteria of comparison. No such trial is available at present, so that the comparison can only rest on speculations and less demonstrative facts. As it stands, it is not in favour of intracoronary thrombolysis.
Boissel
J P
JP
Unité de Pharmacologie clinique, Lyon.
D003327:Coronary Disease / Q000188:drug therapy*; D003328:Coronary Thrombosis / Q000188:drug therapy* / Q000401:mortality; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D013300:Streptokinase / Q000008:administration & dosage; D013997:Time Factors
D005343:Fibrinolytic Agents; D013300:Streptokinase
Confrontation thrombolyse intraveineuse et thrombolyse intracoronarienne.